Suzuki Receives 2023 AstraZeneca Lung Cancer Research Award

The Board of Directors of The Thoracic Surgery Foundation has named Kei Suzuki, MD, the recipient of the 2023 AstraZeneca Lung Cancer Research Award. Suzuki was recognized for his project, “Single-cell RNA sequence profiling of tumor-immune microenvironment for precision therapy in resectable lung cancer.”  “This funding is crucial to take the research to the next…

Read More

Breathing Easier with Interventional Pulmonology

Interventional pulmonology provides minimally invasive techniques to help diagnose and treat lung diseases. Your lungs bring oxygen into the body and remove carbon dioxide waste. Many different diseases impair lung function and diminish a person’s quality of life. The Interventional Pulmonology (IP) program at Inova Schar Cancer Institute provides minimally invasive procedures and therapies to…

Read More

Endurance Sports and Colorectal Cancer: Is There a Connection?

Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. He serves as the Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program. After treating three ultramarathoners who had developed colorectal cancer in recent years, I had a suspicion: This could be more than a coincidence. I found…

Read More

Inova Saville Cancer Screening and Prevention Center Joins an International Effort to Fight Pancreatic Cancer

Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology.  We know the realities of pancreatic cancer. It is a disease that caused 48,220 deaths in the United States in 2021, and 466,003 worldwide in 2020. It…

Read More

Is Prostate Cancer Slow Growing? Often, Yes — But That’s Not the Whole Story

Doctor giving man checkup in exam room

Prostate cancer, unlike other forms of cancer, often grows slowly. That fact can make screening, treatment and potential outcomes seem a little less intimidating. However, prostate cancer’s slow-growing tendency can obscure other, more complicated aspects of detection and treatment. First, decisions on when to get screened and how to respond to the results are complex,…

Read More

Study Finds New Therapy Effective for Common, Advanced Bladder Cancer

Following standard chemotherapy, Avelumab was found to increase the overall survival of patients with advanced urothelial bladder cancer. According to the North American Association of Central Cancer Registries, more than 80,000 Americans will be diagnosed with bladder cancer in 2022 with an anticipated loss of 17,000 patients to the disease. Most of these cases are…

Read More